On this page
FGD1
FYVE, RhoGEF and PH domain containing 1
The FGD1 gene provides instructions for a protein that acts as a guanine nucleotide exchange factor, playing a key role in cell signalling pathways important for bone development and extracellular matrix remodelling. The FGD1 gene encodes a protein integral to cellular communication, specifically by activating the Cdc42 GTPase.
FGD1 is located on the short (p) arm of chromosome X, at band Xp11.22. Arm ratio per GRCh38 - banding schematic.
Explore chromosome X in the library →Available at Jeen Health
Clinical tests that include this
Overview
The FGD1 gene, also known as FYVE, RhoGEF and PH domain containing 1, is essential for producing a protein that functions as a guanine nucleotide exchange factor (GEF). GEFs are critical in cellular signalling by activating specific proteins called GTPases. The FGD1 protein's role in activating the Cdc42 GTPase is particularly important for bone development and the remodelling of the extracellular matrix, which is the network of proteins and molecules surrounding cells.
What the gene does
The FGD1 protein operates by activating the Cdc42 GTPase, a process initiated by stimulating the exchange of GDP for GTP. GTPases are effectively switched 'on' when bound to GTP and 'off' when bound to GDP, making FGD1 a key regulator of this cellular switch. The activated Cdc42 subsequently transmits signals vital for various aspects of development, both before and after birth, with a particular emphasis on bone development. Beyond its role in bone, the FGD1 protein may also contribute to the maintenance and remodelling of the extracellular matrix, which is a complex scaffold of proteins and other molecules found in the spaces between cells. This function appears to influence cell movement and the remodelling of blood vessels.
Video: Genetics 101
Chromosome location
The FGD1 gene is situated on the short arm of the X chromosome at position 11.22, a region denoted as Xp11.22. This chromosomal location means that the gene's inheritance pattern can vary and is often linked.
Protein structure
The FGD1 protein is 961 amino acids long and features several distinct domains and regions. It includes a large disordered region at its N-terminus, spanning amino acids 1-353. Within this region, an SH3-binding motif is found between amino acids 171-187. A Dbl homology (DH) domain, crucial for GEF activity, is located from amino acids 373-561. Following this, there are two pleckstrin homology (PH) domains, with PH 1 positioned from amino acids 590-689 and PH 2 from amino acids 821-921. An intervening disordered region is present from amino acids 702-726. A FYVE-type zinc finger motif, typically involved in membrane targeting, occurs between amino acids 730-790. Another disordered region is found towards the C-terminus, from amino acids 925-961.
Key variants
Genetic variations, often called variants, within the FGD1 gene can alter the protein's structure or function. Such changes may lead to a non-functional or abnormally functioning FGD1 protein, which can disrupt critical cellular signalling pathways. The specific impact of a variant can depend on its location and the type of change it introduces to the gene sequence.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1076del | p.Leu359fs | Pathogenic | ★★☆☆ | Inborn genetic diseases |
c.1327C>T | p.Arg443Cys | Pathogenic/Likely pathogenic | ★★☆☆ | FGD1-related disorder |
c.1565G>A | p.Arg522His | Pathogenic/Likely pathogenic | ★★☆☆ | Aarskog syndrome |
c.1699C>T | p.Arg567Ter | Pathogenic/Likely pathogenic | ★★☆☆ | FGD1-related disorder |
c.1829G>A | p.Arg610Gln | Pathogenic | ★★☆☆ | not provided |
c.1966C>T | p.Arg656Ter | Pathogenic | ★★☆☆ | Aarskog syndrome |
c.2016-36A>T | - | Pathogenic/Likely pathogenic | ★★☆☆ | Aarskog syndrome |
c.26dup | p.Ala10fs | Pathogenic | ★★☆☆ | Inborn genetic diseases |
c.277dup | p.Tyr93fs | Pathogenic/Likely pathogenic | ★★☆☆ | Aarskog syndrome |
c.527del | p.Pro176fs | Pathogenic/Likely pathogenic | ★★☆☆ | Inborn genetic diseases |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Variants in the FGD1 gene are associated with inherited conditions, notably Aarskog-Scott syndrome (XLR). This rare condition primarily affects males and is characterised by distinctive facial features, genital abnormalities, short stature in childhood, and various other skeletal abnormalities. The underlying cause is typically an abnormally functioning FGD1 protein.
UK clinical status
The FGD1 gene is assessed by NHS England's Genomic Medicine Service, with several clinical panels indicating its relevance. It is currently listed as green for Clefting, DDG2P, Intellectual disability, IUGR and IGF abnormalities, and Limb disorders. Additionally, it holds a green status for Foetal anomalies under PanelApp R21.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What does the FGD1 gene do?
The FGD1 gene provides instructions for a protein that acts as a guanine nucleotide exchange factor (GEF). This protein activates the Cdc42 GTPase, which is crucial for signalling pathways involved in bone development and extracellular matrix remodelling.
What is Aarskog-Scott syndrome?
Aarskog-Scott syndrome is a rare inherited condition primarily affecting males, caused by variants in the FGD1 gene. It is characterised by specific facial features, genital abnormalities, short stature, and other skeletal issues.
How can variants in the FGD1 gene affect health?
Variants in the FGD1 gene can lead to the production of an abnormally functioning FGD1 protein. This can disrupt vital cellular signalling, particularly impacting bone development and extracellular matrix maintenance, as seen in conditions like Aarskog-Scott syndrome.
References
- Pedigo NG, Van Delden D, Walters L. Minireview: Role of genetic changes of faciogenital dysplasia protein 1 in human disease. Physiological genomics. 2016. PMID: 27199457
- Oshima T, Fujino T, Ando K. Role of FGD1, a Cdc42 guanine nucleotide exchange factor, in epidermal growth factor-stimulated c-Jun NH2-terminal kinase activation and cell migration. Biological & pharmaceutical bulletin. 2011. PMID: 21212517
- Gao L, Gorski JL, Chen CS. The Cdc42 guanine nucleotide exchange factor FGD1 regulates osteogenesis in human mesenchymal stem cells. The American journal of pathology. 2011. PMID: 21356349
- Daubon T, Buccione R, Génot E. The Aarskog-Scott syndrome protein Fgd1 regulates podosome formation and extracellular matrix remodeling in transforming growth factor β-stimulated aortic endothelial cells. Molecular and cellular biology. 2011. PMID: 21911474
- Orrico A, Galli L, Cavaliere ML. Phenotypic and molecular characterisation of the Aarskog-Scott syndrome: a survey of the clinical variability in light of FGD1 mutation analysis in 46 patients. European journal of human genetics : EJHG. 2004. PMID: 14560308
- Hou P, Estrada L, Kinley AW. Fgd1, the Cdc42 GEF responsible for Faciogenital Dysplasia, directly interacts with cortactin and mAbp1 to modulate cell shape. Human molecular genetics. 2003. PMID: 12913069
- Estrada L, Caron E, Gorski JL. Fgd1, the Cdc42 guanine nucleotide exchange factor responsible for faciogenital dysplasia, is localized to the subcortical actin cytoskeleton and Golgi membrane. Human molecular genetics. 2001. PMID: 11181572
- Gorski JL, Estrada L, Hu C. Skeletal-specific expression of Fgd1 during bone formation and skeletal defects in faciogenital dysplasia (FGDY; Aarskog syndrome). Developmental dynamics : an official publication of the American Association of Anatomists. 2000. PMID: 10906777